Agenda for the California Healthcare Policy Forum Revealed.Event to Address Healthcare Reform's Impact on Biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. Innovation LA JOLLA La Jolla (lə hoi`yə), on the Pacific Ocean, S Calif., an uninc. district within the confines of San Diego; founded 1869. The beautiful ocean beaches, in particular La Jolla shores and Black's Beach, and sea-washed caves attract visitors and , Calif. -- CHI-California Healthcare Institute today announced its agenda and newly confirmed speakers for the 2009 California Healthcare Policy Forum to be held Nov. 5, at the InterContinental Mark Hopkins San Francisco InterContinental Mark Hopkins Hotel, is a 19 story luxury hotel located at Number One Nob Hill & 999 California Street, San Francisco, California, United States. The hotel is owned by the InterContinental Hotels Group. Hotel, from 11:30 a.m. to 6:00 p.m. Sharon Levine, M.D., associate executive medical director, The Permanente Medical Group, will participate in the Healthcare Reform and Assessing the Value of Medical Innovation presentation. Assemblymember Jose Solorio Jose J. Solorio (born September 28 1970) was elected to the California State Assembly in 2006. He represents the 69th Assembly District, which includes the cities of Santa Ana, Anaheim, and Garden Grove. will also speak at the event. This annual statewide conference brings together opinion leaders from the science, business and public sectors to discuss opportunities and issues facing the biomedical community. The forum facilitates the confluence of the private and academic research sectors with policy makers to ensure that innovation will continue to benefit Americans in the future. "Healthcare reform is high on the agenda of our state and our nation," said CHI President and Chief Executive Officer David L. Gollaher, Ph.D. "This forum brings together opinion leaders from California's healthcare community, like Sharon Levine and Mark Smith, CEOs of medical device and biotechnology companies Top 100 Biotechnology Companies The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. , with policymakers. Together, we will address how to expand coverage and access while sustaining investment in future medical technologies." The day will begin with a networking luncheon at the Top of The Mark restaurant at the InterContinental Mark Hopkins at 11:30 a.m. Following the lunch, the Healthcare Reform and Assessing the Value of Medical Innovation discussion will include Gollaher, Michael Goldberg, partner, Mohr Davidow Ventures, Alan M. Garber, M.D., Ph.D., director, center for health policy and center for primary care and outcomes research, Stanford University Stanford University, at Stanford, Calif.; coeducational; chartered 1885, opened 1891 as Leland Stanford Junior Univ. (still the legal name). The original campus was designed by Frederick Law Olmsted. David Starr Jordan was its first president. , Levine, and futurist and author Ian Morrison, Ph.D. will moderate this conversation focused on the competing priorities within current healthcare reform proposals. Next, Assemblymember Nathan Fletcher will address the attendees on California's role in the healthcare debate. Following his address, top biomedical industry executives in the state of California, including Hans Bishop, president, specialty medicine, Bayer HealthCare LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control ; Robert B. Hance, president, Abbott Vascular; and Carl W. Hull, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Gen-Probe Incorporated will discuss how proposed healthcare policies will affect their ability to innovate. Next, attendees will meet Assemblymember Jose Solorio during a solon Solon, Athenian statesman Solon (sō`lən), c.639–c.559 B.C., Athenian statesman, lawgiver, and reformer. He was also a poet, and some of his patriotic verse in the Ionic dialect is extant. At some time (perhaps c.600 B.C. interactive session. The forum will conclude with Innovation at the Crossroads: Cardiovascular Medicine and Infectious Disease Infectious disease A pathological condition spread among biological species. Infectious diseases, although varied in their effects, are always associated with viruses, bacteria, fungi, protozoa, multicellular parasites and aberrant proteins known as prions. featuring Michael A. Mussallem, chairman and CEO, Edwards Lifesciences, John C. Martin, Ph.D., chairman of the board and CEO, Gilead Sciences and Mark D. Smith, M.D., M.B.A., president and CEO, California HealthCare Foundation. The registration rate for CHI members is $295; non-members is $445 and academic and nonprofits is $95. Visit www.chi.org/hcpf/default.aspx or call 858-551-6677 to register. Members of the media may register at no cost. Visit the forum Web site for details. About CHI CHI represents more than 250 leading biotechnology, medical device, diagnostics, and pharmaceutical companies, and public and private academic biomedical research organizations. CHI's mission is to advance responsible public policies that foster medical innovation and promote scientific discovery. CHI's Web site is www.chi.org. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion